Invicta Diagnostic Limited (NSE:INVICTA)

Market Cap	910.21M
Revenue (ttm)	301.81M
Net Income (ttm)	48.92M
Shares Out	12.57M
EPS (ttm)	5.81
PE Ratio	12.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209,600
Average Volume	48,080
Open	73.00
Previous Close	73.00
Day's Range	64.00 - 76.00
52-Week Range	65.05 - 105.00
Beta	n/a
RSI	39.61
Earnings Date	n/a

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo...

• Industry: Medical Laboratories
• Founded: 2016
• Employees: 105
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INVICTA

Financial Performance

In 2024, Invicta Diagnostic's revenue was 301.81 million, an increase of 89.84% compared to the previous year's 158.98 million. Earnings were 48.92 million, an increase of 30.04%.